• S&P 500: 1,351.95
  • Change: 0.15%
$11.96 -0.05 (-0.42%)
2/9/2012 4:00 PM

Akorn, Inc. (NASDAQ:AKRX)

CAPS Rating: 3 out of 5

The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.

Current Price $11.96 Mkt Cap $1.13B
Open $11.99 P/E Ratio 15.40
Prev. Close $12.01 Div. (Yield) N/A (N/A)
Daily Range $11.79 - $12.12 Volume 715,536
52-Wk Range $4.97 - $12.25 Avg. Daily Vol. 0

Caps

How do you think AKRX will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

159 Outperform
12 Underperform
 

All-Star Players

42 Outperform
6 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top AKRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

HealthcareGuy (97.83)
Submitted December 29, 2010

Akorn, is a generic pharma company that has been remade by successful healthcare turnaround investor John Kapoor (Chariman of the Board). The major catalyst for this name, will be FDA approval of AKRX’s generic version of Vancocin (first to file,… More

OriginalBarnacle (< 20)
Submitted August 23, 2007

P/b = 10.2P/S = 12.7No earningsMargins are worse with increasing inventory.Price change over 106%

AKRX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about AKRX.

Recs

0
Member Avatar cobradon (99.33) Submitted: 2/1/2012 6:05:44 PM : Outperform Start Price: $3.32 AKRX Score: +232.39

I saw one of the rating agencies tout this as a raging buy.... But, beyond that I like the whole pharma section as the baby boomers become in need.

Recs

0
Member Avatar NuclearSteve (< 20) Submitted: 12/28/2011 2:26:56 PM : Outperform Start Price: $11.22 AKRX Score: -1.62

Following this for awhile. Bullish biotech from my own screens and the StockTwits50.

Recs

0
Member Avatar reddingrunner (94.44) Submitted: 12/24/2011 8:30:41 AM : Outperform Start Price: $11.50 AKRX Score: -3.28

growth, Kirk Growth screen, Zack's #1 rank

Leaderboard

Find the members with the highest scoring picks in AKRX.

Score Leader

jkleiman

jkleiman (53.82) Score: +657.70

The Score Leader is the player with the highest score across all their picks in AKRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jkleiman 53.82 11/10/2009 Outperform 5Y $1.53 +681.70% +24.00% +657.70 0 Comment
marksaal 92.58 10/19/2009 Outperform 3Y $1.55 +671.61% +23.29% +648.32 0 Comment
joker245 95.44 11/12/2009 Outperform 5Y $1.58 +656.96% +23.05% +633.91 0 Comment
branwann 89.56 11/12/2009 Outperform 5Y $1.58 +656.96% +23.05% +633.91 0 Comment
LRiquel86 < 20 11/20/2009 Outperform 5Y $1.58 +656.96% +23.90% +633.06 0 Comment
Bonnell65 91.17 11/16/2009 Outperform 5Y $1.59 +652.20% +22.63% +629.57 0 Comment
CetiAlphaV 72.66 10/20/2009 Outperform 5Y $1.60 +647.50% +23.11% +624.39 0 Comment
terpgrad 81.91 11/11/2009 Outperform 3Y $1.61 +642.86% +22.98% +619.88 0 Comment
PayrollGeek 81.84 1/25/2010 Outperform NS $1.65 +624.85% +22.82% +602.03 0 Comment
MicroMikey 73.52 3/9/2010 Outperform 5Y $1.72 +595.35% +18.81% +576.54 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackNeedham 92.43 1/18/2012 Outperform NS $10.88 +9.93% +4.68% +5.25 0 Comment
TrackDeutscheSec 92.40 9/16/2011 Outperform NS $9.03 +32.45% +11.71% +20.74 0 Comment
TrackRodmanRen < 20 7/15/2010 Outperform NS $3.19 +274.92% +23.49% +251.43 0 Comment
TrackCreditSuiss 93.26 2/26/2009 Outperform NS $1.97 +507.11% +77.05% +430.05 0 Comment
TrackFBRCapitalM 84.41 10/13/2006 Outperform NS $4.09 +61.86% -2.25% +64.11 2/8/2008 @ $6.62 0 Comment

Featured Broker Partners